$PFE Recent News DuPont, Pfizer are top decliners in Dow

New Post Public Reply Private Reply Replies (0) Message Board

Dec 4, 2013 at 7:00 PM

$PFE Recent News

DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com

Pfizer: Transformation Pace And Oncology Success Determine Potential Returns 4:40 p.m. Today - Seeking Alpha
Pfizer cuts 150 jobs in Ireland 3:16 p.m. Today - Seeking Alpha
Pfizer Expands Clinical Trial Data Access Policy, Launches Data Access Portal 11:10 a.m. Today - benzinga.com
Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore 11:09 a.m. Today - 247WallSt.com
Medicines Co. Acquires Rempex Pharma; Street Applauds 10:21 a.m. Today - Investors Business Daily
Stock Market News for December 4, 2013 - Market News 10:06 a.m. Today - Zacks.com
Best Biotech CEO of 2013: Your Vote Counts 8:07 a.m. Today - TheStreet.com
Pfizer Inc (PFE): Today's Featured Drugs Laggard 5:03 p.m. Dec. 3, 2013 - TheStreet.com
Dow Today: Pfizer (PFE) Lower 1:30 p.m. Dec. 3, 2013 - TheStreet.com
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst 10:01 a.m. Dec. 3, 2013 - Seeking Alpha
Will GlaxoSmithKline Head Higher After Recent Headlines? 8:53 a.m. Dec. 3, 2013 - Wall St. Cheat Sheet
Pfizer out, AbbVie in on Goldman's CL-Buy list 8:45 a.m. Dec. 3, 2013 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More 8:29 a.m. Dec. 3, 2013 - 247WallSt.com
Cramer's Mad Money - Hey, Hey, Ho, Ho, John Chambers Has To Go (12/2/13) 5:52 a.m. Dec. 3, 2013 - Seeking Alpha
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Athersys to Raise Funds - Analyst Blog 5:20 p.m. Dec. 2, 2013 - Zacks.com
Buy Recommendation Reiterated For Pfizer Inc 9:00 a.m. Nov. 29, 2013 - TheStreet.com
GlaxoSmithKline: What's The Next Growth Driver? 2:38 p.m. Nov. 26, 2013 - Seeking Alpha
Stock Market News for November 26, 2013 - Market News 10:06 a.m. Nov. 26, 2013 - Zacks.com

Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal 12:09 p.m. Today - BusinessWire
Bullish Stocks Commentary: Pfizer Inc, Zynga Inc, OCZ Technology Group, EnteroMedics Inc 9:01 a.m. Today - ACCESSWIRE
Traders Buzz: Pfizer Inc, Chesapeake Energy Corporation, Alcatel Lucent SA, Advanced Micro Devices 10:02 a.m. Dec. 3, 2013 - ACCESSWIRE
Pfizer Acquires Polocard, Poland's Leading Over-The-Counter Heart Attack Prevention Brand 8:30 a.m. Dec. 2, 2013 - BusinessWire
New Products, Positive Clinical Trial Results, FDA Submissions and Stock Price Updates - Research Report on Pfizer, Cubist, Zoetis, Edwards Lifesciences, and C.R. Bard 8:00 a.m. Nov. 28, 2013 - PR Newswire
FDA Approvals, New Appointments, and Official Statements - Research Report on Pfizer, Aetna, Lilly, GSK, and Sanofi 8:00 a.m. Nov. 27, 2013 - PR Newswire
Just in Time for Peak Travel Season, Introducing New Robitussin(R) DM Max Liquid-Filled Capsules 9:00 a.m. Nov. 25, 2013 - BusinessWire
Upcoming Conference Schedules, Orphan Drug Designations and Stock Price Updates - Research Report on Pfizer, ICU Medical, CONMED, Gentium, and Repros Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV 9:00 a.m. Nov. 22, 2013 - PR Newswire
Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Nov. 21, 2013 - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Nov. 21, 2013 - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CDTL's E-Drive and EMB Shape Future of Automation

A Bumpy Ride Towards Future of Commercial Vehicles In the midst of a bustling Hannover, CDTL, that plucky contender in e-drive systems, is making noise at IAA Transportation 2026. Now, if there's one thing I've learned watching this circus we call the auto industry, it's that innovation rarely strolls in with a polite knock. It barges through the door, often leaving a...

Yas Island's Bold Move: Expanding With Potter Magic

Potter Magic Takes Over Warner Bros. World Abu Dhabi Call it a stroke of wizardry or plain savvy business sense, Miral and Warner Bros. Discovery Global Experiences are betting large on Harry Potter with a trio of themed lands at Warner Bros. World Abu Dhabi. Brace yourselves, because this ain't your mother's theme park nostalgia—this is about breathing new life into a...

AB SKF to Hold EGM, Spin Off Automotive Assets

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Stem Cell Market Set for Major Gains to 2031

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Ping An Climbs Sustainability Ladder, Scores A+ Rating

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

Sky Labs' CART Monitor Advances BP Monitoring Tech

Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...

vivo and UNESCO Unite Youth for Nature Stories

Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...

Hims & Hers Health Hit by FTC Claims and Class Action

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...